• EdU Flow Cytometry Assay Kits (Cy3): Precision in S-Phase An

  2026-06-10

  EdU Flow Cytometry Assay Kits (Cy3) enable sensitive, denaturation-free detection of DNA synthesis, dramatically improving cell proliferation and genotoxicity workflows. This article explores advanced applications, troubleshooting, and experimental enhancements grounded in recent mechanistic breakthroughs—including the SP1/ADAM10/DRP1 axis in vascular remodeling.

• Light-Inducible RNA Switches Enable Precision Gene Therapy C

  2026-06-10

  The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP), enabling precise, reversible translational regulation of therapeutic genes in vivo. This optogenetic gene switch is compatible with various delivery routes and represents a major step toward safer, on-demand gene and cell therapies for chronic diseases.

• Nelfinavir Mesylate: Advanced HIV-1 Protease Inhibitor Workf

  2026-06-09

  Nelfinavir Mesylate is redefining experimental design across HIV infection research and ferroptosis modulation, enabling precision control of viral replication and protein homeostasis. This article delivers actionable protocols, troubleshooting guidance, and evidence-backed workflow enhancements using APExBIO's trusted reagent.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Technical Guidance

  2026-06-09

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody (SKU K1223) addresses the need for reliable, high-specificity secondary detection of rabbit IgG in immunoassays, including Western blot, ELISA, and IHC. It is not intended for diagnostic or clinical use, and its performance depends on adherence to recommended storage and workflow practices.

• Oltipraz in MASLD: Nrf2 Activation and Next-Gen Chemoprevent

  2026-06-08

  Discover how Oltipraz, a potent Nrf2 pathway activator, uniquely advances chemopreventive strategies for metabolic associated steatotic liver disease (MASLD) by bridging phase II detoxification and autophagy/ferroptosis modulation. This article synthesizes molecular insights, protocol guidance, and translational implications.

• Recombinant Mouse M-CSF: Metabolic Reprogramming and Macroph

  2026-06-08

  Explore the pivotal role of Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) without Tag in modulating macrophage metabolism and functional plasticity. This in-depth article reveals cutting-edge insights into M-CSF-driven glycolytic reprogramming and fibrotic disease modeling, offering a distinct perspective for advanced immunology research.

• Sulfachloropyridazine Alters Cecal Microbiota in E. tenella

  2026-06-07

  This study systematically examined how sulfachlorpyridazine, ethanamizuril, and their combination modulate the cecal microbial and metabolite profiles in chickens infected with Eimeria tenella. The findings illuminate drug-specific effects on both harmful and commensal bacteria, informing future approaches to manage avian coccidiosis and its associated microbiome disturbances.

• Mianserin HCl: Applied Protocols for 5-HT2 Receptor Antagoni

  2026-06-06

  Mianserin HCl stands out as a 5-HT2 receptor antagonist with unique noradrenergic actions, enabling nuanced investigation of serotonin signaling and novel antipathogenic models. This article provides actionable workflows, advanced use-case integration, and troubleshooting strategies, bridging experimental antidepressant research with innovations in cell cytotoxicity and host-guest chemistry.

• QSHXO Ameliorates MASLD via Autophagy Activation and Ferropt

  2026-06-05

  Liu et al. demonstrate that Qushi Huoxue ointment (QSHXO) alleviates metabolic associated steatotic liver disease (MASLD) in mice by promoting autophagy and suppressing ferroptosis. This dual mechanism clarifies the molecular basis of QSHXO's hepatoprotective effects and offers direction for targeted MASLD interventions.

• Coumestrol in RA: Mechanistic Innovation for Translational R

  2026-06-05

  This thought-leadership article explores the dual mechanistic role of Coumestrol—a high-purity phytoestrogen estrogen receptor antagonist—in rheumatoid arthritis (RA) translational research. By synthesizing recent evidence on ferroptosis induction, estrogen receptor signaling, and nuclear receptor modulation, the piece provides actionable guidance for researchers seeking robust, disease-relevant models and workflows. The article positions APExBIO’s Coumestrol (SKU C5832) as a uniquely versatile tool and escalates discourse beyond standard product descriptions, integrating biological rationale, experimental validation, and strategic outlook.

• CCK-8s Stimulates ANP Secretion via NOX4–PGC-1α–PPAR Signali

  2026-06-04

  The referenced study uncovers a novel signaling pathway by which sulfated cholecystokinin octapeptide (CCK-8s) promotes atrial natriuretic peptide (ANP) secretion in isolated rat atria. By elucidating the role of NOX4–PGC-1α–PPARα/PPARγ in this process, the work advances understanding of cardiac hormone regulation and its metabolic implications.

• Pandemic Response Box Reveals Antifungal Hits Against Candid

  2026-06-04

  This study systematically screened the MMV Pandemic Response Box for activity against multidrug-resistant (MDR) bacterial and fungal clinical isolates, including Candida albicans and C. auris. The findings highlight several compounds with potent in vitro inhibition, informing future antifungal development and the ongoing search for agents active against resistant Candida species.

• Rapamycin (Sirolimus): Tumor Microenvironment and Resistance

  2026-06-03

  Explore how Rapamycin (Sirolimus) modulates tumor microenvironment dynamics and resistance mechanisms, advancing mTOR pathway research. Our analysis offers unique insight into stem-like tumor cell persistence and practical assay implications.

• Berberrubine Chloride: Translational Insights from Urate Mod

  2026-06-03

  Explore the advanced mechanisms of Berberrubine chloride, a potent anti-hyperuricemia agent and anti-colorectal cancer compound. This article delivers a unique, translational perspective linking urate transporter regulation and oncogenic pathway inhibition, grounded in recent scientific evidence.

• Ellagic Acid: Selective CK2 Inhibitor for Cancer Biology Res

  2026-06-02

  Ellagic acid is emerging as a gold-standard tool for dissecting casein kinase 2 signaling in cancer biology and oxidative stress assays. Its unique selectivity, ATP-competitive mechanism, and robust antitumor properties enable precise experimental workflows, with protocol insights and troubleshooting guidance to maximize data quality.

15694 records 2/1047 page Previous Next 12345 下5页 Last page